Concepedia

Katie Steenackers

KS

Statistics

Publications

5

Citations

435

H-Index

5

Active since

2020

Affiliations

University of Antwerp(Current)

Ghent University Hospital

GlaxoSmithKline (Belgium)

Los Angeles Clinical Trials

Catholic University of Korea

Katie Steenackers is an author at University of Antwerp specializing in veterinary medicine, infectious diseases, and vaccine efficacy.

Publications per year

2020–2024

5

Publications

5

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Michael G. Ison, Alberto Papi, Eugene Athan et al. · Clinical Infectious Diseases · 2024 · 162 citations · Full text

, , +17

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

Isabel Leroux‐Roels, Matthew Davis, Katie Steenackers et al. · The Journal of Infectious Diseases · 2022 · 118 citations · Full text

, , +17

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials

Ilse De Coster, Isabel Leroux‐Roels, Ananda S Bandyopadhyay et al. · The Lancet · 2020 · 84 citations · Full text

, , +17

Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions

Robert G. Feldman, Raffaele Antonelli Incalzi, Katie Steenackers et al. · Clinical Infectious Diseases · 2023 · 52 citations · Full text

, , +17

Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study

Silvia Narejos Pérez, Josep Ramón, Airi Põder et al. · Open Forum Infectious Diseases · 2023 · 19 citations · Full text

, , +17

1–5 of 5